In light of our findings that M0 macrophages accumulate in high-risk PAC subgroups and may skew toward a protumoral (M2-like) phenotype, targeting macrophage polarization—whether via CD47/SIRPα blockade or other agents—could be a promising strategy. This evidence concerns the gene SIRPA and gonorrhea.